MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Synucleinopathies"

  • 2023 International Congress

    Epigenetic clocks suggest accelerated ageing in isolated REM Sleep Behavior Disorder patients

    L. Baldelli, C. Pirazzini, L. Sambati, F. Ravaioli, D. Gentilini, G. Calandra-Buonaura, P. Guaraldi, C. Franceschi, P. Cortelli, P. Garagnani, MG. Bacalini, F. Provini (Bologna, Italy)

    Objective: To investigate biological aging in videopolysomnography (vPSG)-confirmed isolated REM Sleep Behavior Disorder (iRBD) patients and vPSG-negative controls, using DNA methylation-based epigenetic clocks. Background: Isolated…
  • 2023 International Congress

    The role of RNA-carrying exosomes in synaptic physiology and in synucleinopathies

    A. Chopra, T. Outeiro (Göttingen, Germany)

    Objective: Our goals were: (i) to characterize the molecular mechanisms associated with the transfer of miRNAs from astrocytes to neuronal synapses via exosomes in transgenic…
  • 2023 International Congress

    Artificial Intelligence to detect and classify tremors in patients with Parkinson’s disease and related conditions

    T. Elshourbagy, M. Hernandez, G. Mckay, J. Brasic (Cairo, Egypt)

    Objective: To develop a machine learning program to detect and classify tremors in patients with Parkinson's disease (PD) and related conditions. Background: PD is the…
  • 2022 International Congress

    Intestinal microbial dysbiosis promotes prebiotic-reversible inflammation in Parkinson’s disease

    R. Manfready, D. Hall, C. Goetz, A. Keshavarzian (Chicago, USA)

    Objective: To determine the functional effects of disrupted intestinal microbiota in Parkinson’s disease (PD), particularly the impacts of dysbiosis on inflammation, neuroprotective hormone secretion, and…
  • 2022 International Congress

    Prevalence and distribution of disease-associated alpha-synuclein in a homeless population

    N. Visanji, K. Danics, G. Kovacs (Toronto, Canada)

    Objective: To study the prevalence and distribution of pathological alpha-synuclein deposition, throughout the central and peripheral nervous systems, in a homeless population. Background: The homeless…
  • 2022 International Congress

    Marker Progression and Sample Sizes Estimates for Trials in Prodromal Parkinson’s Disease: A Multicenter Study

    S. Joza, M. Hu, KY. Jung, D. Kunz, P. Dusek, D. Arnaldi, B. Högl, L. Ferini-Strambi, M. Terzaghi, F. Sixel-Döring, M. Puligheddu, F. Provini, S. Lewis, J. Liu, J. Bušková, A. Nicoletti, Y. Dauvilliers, C. Bassetti, M. Lawton, HJ. Kim, JS. Sunwoo, F. Bes, K. Sonka, P. Mattioli, A. Stefani, A. Ibrahim, G. Fiamingo, B. Mollenhauer, C. Trenkwalder, M. Figorilli, P. Cortelli, L. Baldelli, K. Ehgoetz Martens, Y. Li, E. Cicero, L. Guiraud, C. Schaefer, A. Pelletier, R. Postuma (Montreal, Canada)

    Objective: To inform the design of randomized neuroprotective trials in prodromal Parkinson’s disease (PD) by assessing the progression of prodromal markers in idiopathic rapid eye…
  • 2022 International Congress

    Relationship between cardiovascular autonomic failure and cognitive performance in the α-synucleinopathies: preliminary cross-sectional analysis of the NHSS registry

    N. Campese, L. Weissmantel, K. Kerer, F. Leys, G. Goebel, L. Zamarian, C. Raccagni, S. Eschlboeck, C. Eckhardt, V. Sidoroff, F. Krismer, R. Granata, M. Perez, J. Palma, P. Millar-Vernetti, R. Ceravolo, S. Kiechl, W. Poewe, K. Seppi, H. Kaufmann, L. Norcliffe-Kaufmann, G. Wenning, A. Fanciulli (Innsbruck, Austria)

    Objective: To compare cognitive performances of patients with α-synucleinopathies with or without cardiovascular dysautonomia. Background: Cardiovascular dysautonomia is a disabling non-motor feature of the α-synucleinopathies and may…
  • 2022 International Congress

    in vivo and autopsy validation of alpha-synuclein seeding activity using RT-QuIC assay in the gastrointestinal tract of patients with Parkinson’s disease

    C. Shin, JY. Han, YP. Choi, SI. Kim, SH. Park, HK. Yang, HJ. Lee, SH. Kong, YS. Suh, HJ. Kim, B. Jeon (Sejong-si, Republic of Korea)

    Objective: To evaluate pathologic alpha-synuclein (AS) seeding activity with Real-time quaking-induced conversion (RT-QuIC) assay using formalin fixed paraffine-embedded (FFPE) tissue of GI tract in Parkinson's disease (PD)…
  • 2022 International Congress

    Dopamine neuron platform for screening molecular mechanisms and inhibitory drugs against alpha-synuclein aggregation

    S. Er, I. Hlushchuk, P. Chmielarz, A. Domanskyi, M. Airavaara (Helsinki, Finland)

    Objective: Optimization of a dopamine neuron based,in vitro platform is beneficial for studying molecular mechanisms of alpha-synuclein aggregation,and screening of inhibitory drugs and deducing their…
  • 2022 International Congress

    Development and validation of clinical scales for defining RBD severity in participants of the North American Prodromal Synucleinopathy (NAPS) consortium

    A. Busicescu (Phoenix, USA)

    Objective: The objective of this study is to assess the internal validity of the REM Sleep Behavior Disorder (RBD) symptom severity scale (RBDSSS) and its…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 18
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley